Abby Hill

Abby Hill is a Sr. Principal Computational Biologist in the Internal Medicine Research Unit at Pfizer, based in Cambridge, Massachusetts.34 She is a computational biologist specializing in drug development for rare and genetic diseases.3

Professional Background

Prior to her current role at Pfizer, Abby Hill held positions at other pharmaceutical companies:

• She previously worked at Novartis Institutes for Biomedical Research in the Chemical Biology and Therapeutics department.1
• She has also been a Senior Scientist at Pfizer before being promoted to her current principal role.

Education and Research

Abby Hill has a strong academic background:

• She attended the Massachusetts Institute of Technology (MIT).3
• As a graduate student at MIT, she presented research on the "Evaluation of network algorithms across multiple data types and applications" at the 2017 Systems Biology Symposium hosted by Clarivate Analytics.2

Skills and Expertise

Abby Hill's expertise lies in:

• Computational biology
• Drug development, particularly for rare and genetic diseases
• Network analysis and algorithms
• Systems biology approaches

Her work involves applying computational methods to advance drug discovery and development, particularly in the context of internal medicine and rare diseases.34

Professional Presence

Abby Hill maintains a professional online presence:

• Her LinkedIn profile can be found under the username abby-hill-4156a112.3
• She is active in the biopharmaceutical research community, having contributed to academic publications and presented at scientific symposiums.12